Why ‘Big Pharma’ isn’t cashing in on the peptide craze
Story summaryThe most popular peptides being bought illegally in Australia are yet to attract serious attention from big pharmaceutical companies, who believe they would not be lucrative or safe enough products to bring to the legitimate market.
Read at The AgeOpens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.